PACBVSSFWL• 7 Days (Normalized)
PACB vs SFWL (Pacific Biosciences of California Inc. vs Shengfeng Development Limited)
Showing Closing Date Range from Sep 29 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
PACB Performance $2.87
+56.83%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
SFWL Performance $8.82
-0.9%
Shengfeng Development Limited
Normalized Baseline0.00%
Alpha Spread Margin PACB LEADS
+57.73 pts
PACB outperforming by 57.73 percentage points
PACBSFWL
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
PACB SFWL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | PACB Price | PACB Gain (%) | SFWL Price | SFWL Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $2.87 | +56.83% | $8.82 | -0.90% | +57.73% |
| Oct 02, 2026 | $2.54 | +38.80% | $8.35 | -6.18% | +44.98% |
| Oct 01, 2026 | $2.51 | +37.16% | $8.81 | -1.01% | +38.17% |
| Sep 30, 2026 | $2.37 | +29.51% | $8.90 | +0.00% | +29.51% |
| Sep 29, 2026 | $1.83 | +0.00% | $8.90 | +0.00% | +0.00% |